Surglasses, a Taichung, Taiwan-based company advancing AR augmented reality surgical navigation systems, raised $6.5M in Pre-A funding.
The round was led by Taiwania Capital with participation from Integrated Capital, 500 STARTUPS V, L.P., Wisdom Capital Limited Partnership, and Sustainable Impact Capital.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Miron Wang, Surglasses is a company dedicated to providing AR augmented reality surgical navigation systems for orthopedics and neurosurgery, along with related products, solutions, and services to enhance healthcare intelligence.
The funds raised will primarily be directed towards accelerating the research, development, and promotion of its innovative product – the Caduceus S AR navigation system. Caduceus S is an FDA510(k) Clearance AR medical technologyspecially designed for complex spinal surgeries. The system allows real-time overlay of 3D spinal anatomy onto the patient during surgical procedures through multiple trackers and a transparent Head-Mounted Display (HMD), providing precise guidance and facilitating surgical operations for surgeons.
In 2022, the company obtained Taiwan Class II medical device approval for its AR navigation system and achieved FDA 510(k) clearance in the United States by the end of the same year, further validating the high quality and safety of its products.
FinSMEs
10/11/2023